Core Viewpoint - Jinyu Jidong (000401.SZ) expects a net profit attributable to shareholders of 180 million to 260 million yuan in 2025, marking a turnaround from losses, while the non-recurring loss is projected to be between 170 million and 270 million yuan [1] Group 1: Financial Performance - The company anticipates a significant improvement in operating performance for 2025, achieving profitability compared to previous losses [1] - The expected net profit range indicates a positive shift in financial health, with a focus on cost reduction and efficiency improvements [1] Group 2: Operational Strategy - The company has been actively engaged in lean operational management and has implemented various measures to reduce costs and enhance efficiency, resulting in a substantial decrease in costs and period expenses year-on-year [1] - Market-oriented integration efforts are ongoing, with strategic optimization and successful operations of newly acquired companies contributing to favorable investment returns [1] Group 3: Market Conditions - Despite facing overall weak market demand, the company has managed to maintain a high level of profitability in its overseas business [1]

转自：证券时报 人民财讯1月14日电，金隅冀东(000401)1月14日发布业绩预告，预计2025年归母净利润1.8亿元—2.6亿 元，上年同期亏损9.91亿元。报告期内，公司多措并举扎实推进降本增效工作，成本与期间费用同比实 现较大幅度下降。同时，公司新并购企业运营情况良好，取得较好的投资回报；海外业务持续保持较高 盈利水平。 ...

每经AI快讯，金隅冀东1月14日晚间发布业绩预告，预计2025年归属于上市公司股东的净利润1.8亿元 ~2.6亿元，同比扭亏为盈。业绩变动主要原因是，报告期内，面对整体偏弱的市场有效需求，公司持续 深耕精益运营管理，多措并举扎实推进降本增效工作，成本与期间费用同比实现较大幅度下降。同时， 公司推动市场化整合，不断优化战略布局，新并购企业运营情况良好，取得较好的投资回报；海外业务 持续保持较高盈利水平。2025年度，公司经营业绩稳步改善，同比实现扭亏为盈。 （记者 曾健辉） 每经头条（nbdtoutiao）——海利生物增值9倍并购的企业，估值8个月"腰斩"，其第一大客户竟是尚未 成立的公司，离奇的事还不少…… ...

Group 1 - The company, Shangfeng Cement, announced the approval of the election of the vice chairman of the board and the supplementary election of members of the specialized committees of the board during its 11th board meeting [1]

公告称，报告期内，公司建材及房地产业务均处于行业下行周期。水泥业务，持续优化战略布局，扎实 推进降本增效工作，经营业绩同比实现扭亏为盈;房地产业务受市场影响，需求减弱，销售价格承压， 影响公司房地产业务经营利润。 智通财经APP讯，金隅集团(02009)发布公告，经公司财务部门初步测算，预计2025年度实现归属于上市 公司股东的净亏损为9-12亿元之间;预计2025年度实现归属于上市公司股东的扣除非经常性损益的净亏 损为34.5-37.5亿元之间。而2024年归属于上市公司股东的净亏损约5.55亿元，归属于上市公司股东的扣 除非经常性损益的净亏损约28.59亿元。 ...

Core Viewpoint - The company, Jinyu Group, anticipates significant net losses for the fiscal year 2025, with projections indicating a loss between 900 million to 1.2 billion yuan, and a loss excluding non-recurring items between 3.45 billion to 3.75 billion yuan [1] Group 1: Financial Projections - For the year 2024, the company expects a net loss of approximately 555 million yuan, with a net loss excluding non-recurring items around 2.859 billion yuan [1] - The anticipated losses for 2025 reflect ongoing challenges in the construction materials and real estate sectors, which are currently experiencing a downturn [1] Group 2: Business Performance - The cement business has managed to turn a profit year-on-year due to strategic optimization and cost reduction efforts [1] - Conversely, the real estate sector is facing weakened demand and pressured sales prices, negatively impacting its operating profits [1]

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其準確 性或完整性亦不發表任何聲明，並明確表示，概不會就本公告全部或任何部分內容而產生或 因依賴該等內容而引致的任何損失承擔任何責任。 北 京 金 隅 集 團 股 份 有 限 公 司 BBMG Corporation* （於中華人民共和國註冊成立的股份有限公司） （股份代號：2009） 海外監管公告 本公告乃北京金隅集團股份有限公司（「本公司」)按香港聯合交易所有限公司證券上市規則 第13.10B條發出。 茲載列本公司於二零二六年一月十四日在中華人民共和國上海證券交易所網站刊登之2025 年度業績預虧公告，僅供參閱。 北京金隅集团股份有限公司 2025 年度业绩预亏公告 本公司董事会及全体董事保证本公告内容不存在虚假记载、误导性陈述或者重 大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 承董事會命 北京金隅集團股份有限公司 主席 姜英武 中國北京，二零二六年一月十四日 於本公告日期，本公司執行董事為姜英武、顧昱及鄭寶金；非執行董事為孔慶輝、顧鐵民及 趙新軍；以及獨立非執行董事為劉太剛、洪永淼、譚建方及尹援平。 * 僅供識 ...

格隆汇1月14日｜金隅集团公告，经本公司财务部门初步测算，预计2025年度实现归属于上市公司股东 的净利润为-90,000—-120,000万元之间。经本公司财务部门初步测算，预计2025年度实现归属于上市公 司股东的扣除非经常性损益的净利润为-345,000—-375,000万元之间。报告期内，公司建材及房地产业 务均处于行业下行周期。水泥业务，持续优化战略布局，扎实推进降本增效工作，经营业绩同比实现扭 亏为盈；房地产业务受市场影响，需求减弱，销售价格承压，影响公司房地产业务经营利润。 ...

人民财讯1月14日电，金隅集团（601992）1月14日公告，预计2025年度实现归属于上市公司股东的净利 润亏损9亿元—12亿元。报告期内，公司建材及房地产业务均处于行业下行周期。水泥业务，持续优化 战略布局，扎实推进降本增效工作，经营业绩同比实现扭亏为盈；房地产业务受市场影响，需求减弱， 销售价格承压，影响公司房地产业务经营利润。 ...

Group 1 - The company Shangfeng Cement held its 11th board meeting on January 14, 2026, via telecommunication to discuss the proposal for the re-election of members of the specialized committees of the board [1] Group 2 - Haili Biological's acquisition has seen a ninefold increase in value, but the valuation has halved in eight months, raising concerns about its first major client, which is a company that has not yet been established [1]